Cysteine [2,4] Disulfide Bond as a New Modifiable Site of α-Conotoxin TxIB
α-Conotoxin TxIB, a selective antagonist of α6/α3β2β3 nicotinic acetylcholine receptor, could be a potential therapeutic agent for addiction and Parkinson’s disease. As a peptide with a complex pharmacophoric conformation, it is important and difficult to find a modifiable site which can be modified...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2021-02-01
|
| Серии: | Marine Drugs |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1660-3397/19/2/119 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|